Cargando…

Oncofetal markers CA 19-9, CA 125 and SP1 in healthy children and in children with malignancy.

Detalles Bibliográficos
Autores principales: Heikinheimo, M., Rajantie, J., Kuusela, P., Kallio, M. J., Siimes, M. A.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1990
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971508/
https://www.ncbi.nlm.nih.gov/pubmed/2245182
_version_ 1782134925434028032
author Heikinheimo, M.
Rajantie, J.
Kuusela, P.
Kallio, M. J.
Siimes, M. A.
author_facet Heikinheimo, M.
Rajantie, J.
Kuusela, P.
Kallio, M. J.
Siimes, M. A.
author_sort Heikinheimo, M.
collection PubMed
description
format Text
id pubmed-1971508
institution National Center for Biotechnology Information
language English
publishDate 1990
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-19715082009-09-10 Oncofetal markers CA 19-9, CA 125 and SP1 in healthy children and in children with malignancy. Heikinheimo, M. Rajantie, J. Kuusela, P. Kallio, M. J. Siimes, M. A. Br J Cancer Research Article Nature Publishing Group 1990-11 /pmc/articles/PMC1971508/ /pubmed/2245182 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Heikinheimo, M.
Rajantie, J.
Kuusela, P.
Kallio, M. J.
Siimes, M. A.
Oncofetal markers CA 19-9, CA 125 and SP1 in healthy children and in children with malignancy.
title Oncofetal markers CA 19-9, CA 125 and SP1 in healthy children and in children with malignancy.
title_full Oncofetal markers CA 19-9, CA 125 and SP1 in healthy children and in children with malignancy.
title_fullStr Oncofetal markers CA 19-9, CA 125 and SP1 in healthy children and in children with malignancy.
title_full_unstemmed Oncofetal markers CA 19-9, CA 125 and SP1 in healthy children and in children with malignancy.
title_short Oncofetal markers CA 19-9, CA 125 and SP1 in healthy children and in children with malignancy.
title_sort oncofetal markers ca 19-9, ca 125 and sp1 in healthy children and in children with malignancy.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971508/
https://www.ncbi.nlm.nih.gov/pubmed/2245182
work_keys_str_mv AT heikinheimom oncofetalmarkersca199ca125andsp1inhealthychildrenandinchildrenwithmalignancy
AT rajantiej oncofetalmarkersca199ca125andsp1inhealthychildrenandinchildrenwithmalignancy
AT kuuselap oncofetalmarkersca199ca125andsp1inhealthychildrenandinchildrenwithmalignancy
AT kalliomj oncofetalmarkersca199ca125andsp1inhealthychildrenandinchildrenwithmalignancy
AT siimesma oncofetalmarkersca199ca125andsp1inhealthychildrenandinchildrenwithmalignancy